Johnson and Johnson’s Ortho-McNeil Pharmaceutical Inc. unit is being sued on behalf of a woman who had been using the company’s Ortho Evra contraceptive patch.
The suit, filed by Parker & Waichman LLP, alleges the woman suffered a pulmonary embolism after using the patch for seven months.
The law firm said Monday, after the financial markets had closed, that recent reports have indicated that the risk of developing blood clots, pulmonary embolism, heart attack and stroke may be significantly higher with the Ortho Evra patch than with oral-contraceptive use.
The firm alleges that Ortho-McNeill was aware of the increased medical risk and failed to adequately warn patients.
Ortho Evra was approved by the Food and Drug Administration in April 2002.
Shares of Johnson & Johnson, based in New Brunswick, N.J., fell 63 cents to close at $64.05 on the New York Stock Exchange.